|
Alfaro R, Legaz I, Jimenez-Coll V, El Kaaoui El Band J, Martinez-Banaclocha H, Galian JA, Parrado A, Mrowiec A, Botella C, Moya-Quiles MR, Boix F, de la Pena-Moral J, Minguela A, Llorente S, Muro M. MicroRNA Expression Changes in Kidney Transplant: Diagnostic Efficacy of miR-150-5p as Potential Rejection Biomarker, Pilot Study. J Clin Med. 2021 Jun 22;10(13):2748. doi: 10.3390/jcm10132748. PubMed PMID: 34206682; PubMed Central PMCID: PMC8268834.
AÑO: 2021; IF: 4.964
|
34206682
|
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723
|
|
Alfaro R, Legaz I, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, de la Pena-Moral J, Moya-Quiles MR, Campillo JA, Minguela A, Llorente S, Muro M. Monitoring of B Cell in Kidney Transplantation: Development of a Novel Clusters Analysis and Role of Transitional B Cells in Transplant Outcome. Diagnostics (Basel). 2021 Apr 1;11(4):641. doi: 10.3390/diagnostics11040641. PubMed PMID: 33916199; PubMed Central PMCID: PMC8065535.
AÑO: 2021; IF: 3.992
|
|
Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci. 2019 Jun 18;17(3):682-693. doi: 10.5114/aoms.2018.80651. eCollection 2021. PubMed PMID: 34025838; PubMed Central PMCID: PMC8130464.
AÑO: 2021; IF: 3.707
|
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|